Starling Oncology Inc (TOI)
NCM · Healthcare · Medical Care Facilities
Closing price as of 2026-08-11 · Source: TEK2day Finance
Key Metrics
About Starling Oncology Inc
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 136.6M | 142.0M | 147.4M | 161.3M |
| Gross Profit | 18.9M | 22.8M | 23.3M | 27.2M |
| Operating Income | (8.1M) | (6.9M) | (6.5M) | (4.6M) |
| Net Income | (16.5M) | (7.5M) | (2.5M) | (9.8M) |
| Diluted EPS | $-0.14 | $-0.06 | $-0.02 | $-0.08 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 252.5M | 324.2M | 393.4M | 502.7M |
| Gross Profit | 52.1M | 59.6M | 54.0M | 76.4M |
| Operating Income | (72.0M) | (60.2M) | (60.1M) | (36.1M) |
| Net Income | 152K | (83.1M) | (64.7M) | (60.6M) |
| Diluted EPS | $-0.20 | $-0.92 | $-0.71 | N/A |